info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Encephalomalacia Market Research Report Information By Types (Leukoencephalomalacia, Polioencephalomalacia), Diagnosis (Brain Scans, Computerized Tomography Scan) Treatment (Medical Treatment, Surgery), End User (Hospitals & Clinics) - Forecast Till 2032


ID: MRFR/MED/3627-HCR | 80 Pages | Author: Kinjoll Dey| October 2024

Encephalomalacia Market Overview


Encephalomalacia Market Size was valued at USD 0.3 Billion in 2023. The Global Encephalomalacia industry is projected to grow from USD 0.4 Billion in 2024 to USD 0.8 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.20% during the forecast period (2024 - 2032).Softening or loss of brain tissue is termed as encephalomalacia and is a severe type of brain damage. Encephalomalacia disorder can also be classified into the three categories depending on their colors and the stages of damage i.e. red softening yellow softening, and white softening.


Encephalomalacia Market


The major causes of encephalomalacia are inflammation or hemorrhages that are a consequence of being afflicted by cerebral infarction, cerebral ischemia, infection, craniocerebral trauma, or another injury. Moreover, stroke is the most commonly known cause of encephalomalacia and stroke can be caused by either a head injury or a brain hemorrhage or both of them cause internal bleeding in brain. 


Furthermore, strokes occur due to reduced or interrupted blood supply to the brain, which is caused by blocked arteries or a burst blood vessel. Moreover, people with diabetes, blood sugar levels that become too high (hyperglycemia) or too low (hypoglycemia) which increases chances of strokes. People who have been rescued from drowning or those who have been resuscitated after a heart attack may not awaken due to lack of oxygen to the brain. Furthermore infections such as encephalitis and meningitis cause swelling or inflammation of the brain, spinal cord or the tissues that surround the brain in severe cases of these infections can result in brain disorder.


Increasing prevalence of neurological disorders, increasing investment by biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drive the growth of the market. Moreover, favorable reimbursement policies, increased application and significant investments in the development of new technologies for the treatment of diseases will fuel the market growth during the forecast period


Furthermore, globalization in healthcare has increased the market growth. Established market players in the developed countries leads the globalization by pushing new products and services into the developing countries and emerging economies. 


According to the World Health Organization estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high-income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden, which is expected to increase further over the coming years.


In March 2024, A long time ago, Mr. X suffered a severe motor vehicle accident. After the crash, he had brain damage, and his left foot dropped, causing him to walk on his toes.


From the outside, it appeared that only the left foot drop and some cognitive and memory impairments were the only consequences of the accident to Mr. X, but this was not true. Mr. X underwent an MRI examination in February 2022, which showed bilateral encephalomalacia.


According to research released in March 2024, household chemicals can impede oligodendrocyte development – cells responsible for myelin production within the human brain.


Encephalomalacia Market Segmentations


The global encephalomalacia market is segmented on the basis of types, diagnosis, treatment, and end user.


On the basis of the type, it is segmented into leukoencephalomalacia (encephalomalacia affecting the white matter), and polioencephalomalacia (encephalomalacia affecting the gray matter).  


On the basis of the diagnosis, it is segmented into blood test, brain scans, and others. A brain scan is further segmented into computerized tomography (CT) scan, magnetic resonance imaging (MRI) and electroencephalography (EEG).


On the basis of the treatment, it is segmented into medical treatment, surgery, and others.


On the basis of the end user, it is segmented into hospitals & clinics, research laboratories, and others.


Encephalomalacia Market Regional Analysis


The Americas dominate the global encephalomalacia market owing to well-developed technology, increasing prevalence of brain disorder, high health care spending, and increasing government support for research & development in the healthcare sector. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the encephalomalacia market in this region.


Europe holds the second position in the global encephalomalacia market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period. For instance, developed economies such countries such as Germany and France are increasing investment in the healthcare domain and are focusing more on hospital infrastructure.


The Asia Pacific is the fastest growing encephalomalacia market owing to the presence of rapidly developing healthcare technology, increasing stressful life, and high healthcare expenditure. Moreover, increasing patient population in countries like India and South Korea are likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is projected to lead the use of advanced equipment, which, in turn, may increase the encephalomalacia market growth in this region.   


On the other hand, the Middle East & Africa holds the least share of the market owing to less availability of funds, limited medical facilities, and deprived political conditions in Africa.


Encephalomalacia Market Key Players


Some of key the players in the market are: 



  • Fujifilm Holdings (Japan)

  • GE Healthcare (U.S.)

  • Siemens Healthcare(U.S.)

  • Philips Healthcare (U.S.)

  • Shimadzu Corporation (Japan)

  • Toshiba Medical Systems Corporation (Japan)

  • Carestream Health (U.S.)

  • Nihon Kohden Corporation (Japan)

  • Electrical Geodesics Inc. (U.S.)

  • Masimo Corporation (U.S.)

  • Hologic (U.S.)

  • Esaote (Italy)


Research Methodology


Global Encephalomalacia Market


Sources: Annual reports, Press release, White paper, and Company presentation


Intended Audience




  • Pharmaceutical and Biotechnological Companies




  • Research and Development (R&D) Companies




  • Ambulatory Care Centers




  • Academic Institutes and Universities




  • Market Research and Consulting Service Providers




  • Potential Investors



Report Attribute/Metric Details
  Market Size   USD 0.8 Billion
  CAGR   9.20%
  Base Year   2023
  Forecast Period   2024-2032
  Historical Data   2020
  Forecast Units  Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered types, diagnosis, treatment, and end user
Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy)
  Key Market Opportunities   Application Area
Key Market Drivers Increasing prevalence of neurological disorders Increasing investment by biotechnology and pharmaceutical industries


Frequently Asked Questions (FAQ) :

Softening of brain tissue leasing to severe brain damage is known as encephalomalacia.

The players in the encephalomalacia market are GE Healthcare (U.S.), Siemens Healthcare(U.S.), Fujifilm Holdings (Japan), Shimadzu Corporation (Japan), Philips Healthcare (U.S.), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), Electrical Geodesics Inc. (U.S.), and others.

The encephalomalacia market CAGR would be 9.20% during the forecast period.

The Americas would lead the encephalomalacia market.

Asia Pacific would enjoy the fastest growth in the encephalomalacia market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.